Skip to main content
. 2017 Feb 16;7(1):21–34. doi: 10.1159/000457810

Table 2.

MRI-based neuroanatomical characteristics for all patients (n = 160) according to impairment status

Variables All patients Dysphagia
Dysarthria
Aphasia
present (n = 76) absent (n = 84) present (n = 71) absent (n = 89) present (n = 52) absent (n = 108)
T2 neurological disease, n (%)
Brain atrophy
 Absent 88 (55.0) 34 (44.7) 54 (64.3) 40 (56.3) 48 (53.9) 23 (44.2) 65 (60.2)
 Mild 46 (28.8) 23 (30.3) 23 (27.4) 17 (23.9) 29 (32.6) 14 (26.9) 32 (29.6)
 Moderate ≤25 >a <b >a <b >a <b
 Severe ≤10
White matter disease
 0 ≤10
 1 83 (51.9) 39 (51.3) 44 (52.4) 39 (54.9) 44 (49.4) 23 (44.2) 60 (55.6)
 2 58 (36.33) 27 (35.5) 31 (36.9) 25 (35.2) 33 (37.1) 21 (40.4) 37 (34.3)
 3 ≤10
Prior covert stroke
 Absent 112 (70.0) 56 (73.7) 56 (66.7) 52 (73.2) 60 (67.4) 38 (73.1) 74 (68.5)
 Single <2 cm 23 (14.4) <a >b <a >b <a >b
 Multiple <2 cm ≤20 >a <b <a >b <a >b
 >2 cm ≤10

DWI acute lesion attributes
Side of lesions, n (%)
 Left side 77 (48.1) 34 (44.7) 43 (51.2) 30 (42.3) 47 (52.8) 39 (75.0) 38 (35.2)
 Right side 58 (36.3) 27 (35.5) 31 (36.9) 28 (39.4) 30 (33.7) <a >b
 Bilateral 25 (15.6) 15 (19.7) 10 (11.9) 13 (18.3) 12 (13.5) <a >b
Supratentorial involvement,c n (%)
 Anterior cerebral artery cortex ≤10
 Middle cerebral artery cortex 88 (55.0) 48 (63.2) 40 (47.6) 37 (52.1) 51 (57.3) 40 (76.9) 48 (44.4)
 Posterior cerebral artery cortex 16 (10.0) <a >b <a >b >a <b
 Basal ganglia 36 (22.5) >a <b 22 (31.0) 14 (15.7) 16 (30.8) 20 (18.5)
 Insula 38 (23.8) >a <b 22 (31.0) 16 (18.0) 24 (46.2) 14 (13.0)
 Internal capsule 46 (28.8) 29 (38.2) 17 (20.2) 27 (38.0) 19 (21.3) 17 (32.7) 29 (26.9)
 Periventricular white matter 68 (42.5) 41 (53.9) 27 (32.1) 33 (46.5) 35 (39.3) 26 (50.0) 42 (38.9)
 Thalamus 16 (10.0) <a >b <a >b >a <b
Infratentorial involvement,c n (%)
 Cerebellum ≤20 >a <b <a >b <a >b
 Midbrain ≤10
 Pons and medulla 33 (20.6) 19 14 21 12 <a >b
Median volume (IQR), cm3
Volume categories, n (%)
23.4 (73.6) 43.4 (116.6) 14.0 (50.8) 21.8 (58.2) 24.5 (90.3) 59.3 (127.6) 10.9 (53.1)
 0–4 cm3 30 (18.8) <a >b 11 (15.5) 19 (21.3) <a >b
 >4–10 cm3 26 (16.3) <a >b 14 (19.7) 12 (13.5) <a >b
 >10–30 cm3 30 (18.8) <a >b 13 (18.3) 17 (19.1) 11 (21.2) 19 (17.6)
 >30–60 cm3 ≤25 >a <b >a <b >a <b
 >60–90 cm3 ≤20 >a <b >a <b <a >b
 >90 cm3 35 (21.9) 20 (26.3) 15 (17.9) 11 (15.5) 24 (27.0) 21 (40.4) 14 (13.0)

Where a small cell size of ≤10 is potentially computable, an indication of trend direction is provided with the symbols < (smaller proportion) or > (larger proportion) across all comparisons for the entire variable. Where total numbers of all patients are ≤10 for a given variable, – denotes suppression of raw numbers for subcategory cells. MRI, magnetic resonance imaging; DWI, diffusion-weighted imaging.

a

Trend compared to absence of the same impairment for the variable in question.

b

Trend compared to presence of the same impairment for the variable in question.

c

Regions of interest were not mutually exclusive.